Top

Published in:

Open Access 01-04-2018 | Pictorial essay

Contrast-enhanced ultrasound (CEUS) in abdominal intervention

Authors: Dean Y. Huang, Gibran T. Yusuf, Mohammad Daneshi, Raymond Ramnarine, Annamaria Deganello, Maria E. Sellars, Paul S. Sidhu

Published in: Abdominal Radiology | Issue 4/2018

Abstract

The introduction of ultrasound contrast agents has rendered contrast-enhanced ultrasound (CEUS) a valuable complementary technique to address clinically significant problems. This pictorial review describes the use of CEUS guidance in abdominal intervention and illustrates such application for a range of clinical indications. Clinical application of CEUS discussed include commonly performed abdominal interventional procedures, such as biopsy, drainage, nephrostomy, biliary intervention, abdominal tumor ablation and its subsequent monitoring, and imaging of vascular complications following abdominal intervention. The purpose of this article is to further familiarize readers with the application of CEUS, particularly its specific strength over alternative imaging modalities, in abdominal intervention.

Schmidbauer J, Remzi M, Memarsadeghi M, et al. (2008) Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol 53(5):1003–1011. https://doi.org/10.1016/j.eururo.2007.11.041 PubMedCrossRef

Uppot RN, Harisinghani MG, Gervais DA (2010) Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol 194(6):1443–1449. https://doi.org/10.2214/AJR.10.4427 PubMedCrossRef

Dietrich CF, Lorentzen T, Appelbaum L, et al. (2016) EFSUMB guidelines on interventional ultrasound (INVUS), part III—abdominal treatment procedures (short version). Ultraschall Med 37(1):27–45. https://doi.org/10.1055/s-0035-1553965 PubMedCrossRef

Jaffe TA, Nelson RC (2016) Image-guided percutaneous drainage: a review. Abdom Radiol (NY) 41(4):629–636. https://doi.org/10.1007/s00261-016-0649-3 CrossRef

Frederick-Dyer K, Ahmad A, Arora SS, Wile G (2016) Difficult biopsy and drainage: just say yes. Abdom Radiol (NY) 41(4):706–719. https://doi.org/10.1007/s00261-016-0666-2 CrossRef

Sheafor DH, Paulson EK, Simmons CM, DeLong DM, Nelson RC (1998) Abdominal percutaneous interventional procedures: comparison of CT and US guidance. Radiology 207:705–710PubMedCrossRef

Gupta S, Madoff DC (2007) Image-guided percutaneous needle biopsy in cancer diagnosis and staging. Tech Vasc Intervent Radiol 10(2):88–101. https://doi.org/10.1053/j.tvir.2007.09.005 CrossRef

Ma X, Arellano RS, Gervais DA et al (2010) Success of image-guided biopsy for small (≤3 cm) focal liver lesions in cirrhotic and noncirrhotic individuals. J Vasc Interv Radiol JVIR 21(10):1539–1547; quiz 1547. https://doi.org/10.1016/j.jvir.2010.05.025

Beland MD, Sternick LA, Baird GL, et al. (2016) Optimizing modality selection for image-guided procedures: an analysis of the challenges to ultrasound guidance. Abdom Radiol (NY) 41(4):590–599. https://doi.org/10.1007/s00261-016-0637-7 CrossRef

10.

Lumason (2017) Prescribing information. https://doi.org/http://www.braccoimaging.com/us-en/products-and-solutions/contrast-enhanced-ultrasound/lumason/prescribing-information. Accessed 21 Jan 2017.

11.

Piscaglia F, Nolsoe C, Dietrich CF, et al. (2012) The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33(1):33–59. https://doi.org/10.1055/s-0031-1281676 PubMedCrossRef

12.

Sidhu PS, Brabrand K, Cantisani V, et al. (2015) EFSUMB guidelines on interventional ultrasound (INVUS), part II. Ultraschall Med 36(6):E15–E35. https://doi.org/10.1055/s-0035-1554036 PubMedCrossRef

13.

Duncan JRTD (2015) Improving performance during image-guided procedures. J Patient Saf 11(4):230–236. https://doi.org/10.1097/PTS.0000000000000115 PubMedPubMedCentralCrossRef

14.

Quaia E (2007) Microbubble ultrasound contrast agents: an update. Eur Radiol 17(8):1995–2008. https://doi.org/10.1007/s00330-007-0623-0 PubMedCrossRef

15.

Harvey CJ, Blomley MJK, Eckersley RJ, Cosgrove DO (2001) Developments in ultrasound contrast media. Eur Radiol 11:675–689PubMedCrossRef

16.

Piscaglia F, Bolondi L, Italian Society for Ultrasound in M, Biology Study Group on Ultrasound Contrast A (2006) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32(9):1369–1375. https://doi.org/10.1016/j.ultrasmedbio.2006.05.031 PubMedCrossRef

17.

Heinzmann A, Muller T, Leitlein J, et al. (2012) Endocavitary contrast enhanced ultrasound (CEUS)–work in progress. Ultraschall Med 33(1):76–84. https://doi.org/10.1055/s-0031-1299056 PubMedCrossRef

18.

Muller T, Leitlein J, Kubicka S, Heinzmann A (2015) Endocavitary contrast-enhanced ultrasound: a technique whose time has come? J Clin Ultrasound JCU 43(2):71–80. https://doi.org/10.1002/jcu.22250 PubMedCrossRef

19.

Chenia F, Hofmeyr GJ, Moolla S, Oratis P (1997) Sonographic hydrotubation using agitated saline: a new technique for improving fallopian tube visualization. Br J Radiol 70(836):833–836. https://doi.org/10.1259/bjr.70.836.9486049 PubMedCrossRef

20.

Hanbury DC, Coulden RA, Farman P, Sherwood T (1990) Ultrasound cystography in the diagnosis of vesicoureteric reflux. Br J Urol 65(3):250–253PubMedCrossRef

21.

Luyao Z, Xiaoyan X, Huixiong X, et al. (2012) Percutaneous ultrasound-guided cholangiography using microbubbles to evaluate the dilated biliary tract: initial experience. Eur Radiol 22(2):371–378. https://doi.org/10.1007/s00330-011-2265-5 PubMedCrossRef

22.

Darge K (2008) Voiding urosonography with ultrasound contrast agents for the diagnosis of vesicoureteric reflux in children. I. Procedure. Pediatric Radiol 38(1):40–53. https://doi.org/10.1007/s00247-007-0529-7 CrossRef

23.

Zhou L, Zhang X, Chen X, et al. (2012) Value of three-dimensional hysterosalpingo-contrast sonography with SonoVue in the assessment of tubal patency. Ultrasound Obstet Gynecol 40(1):93–98. https://doi.org/10.1002/uog.11085 PubMedCrossRef

24.

Goddi A, Novario R, Tanzi F, Di Liberto R, Nucci P (2004) In vitro analysis of ultrasound second generation contrast agent diluted in saline solution. Radiol Med 107(5–6):569–579PubMed

25.

Bartolotta TV, Taibbi A, Midiri M, Lagalla R (2009) Focal liver lesions: contrast-enhanced ultrasound. Abdom Imaging 34(2):193–209. https://doi.org/10.1007/s00261-008-9378-6 PubMedCrossRef

26.

Meloni MF, Andreano A, Laeseke PF, et al. (2008) Contrast-enhanced ultrasonographic findings in a brucellar hepatic abscess. J Ultrasound Med 27(10):1511–1515PubMedCrossRef

27.

Kishina M, Koda M, Tokunaga S, et al. (2015) Usefulness of contrast-enhanced ultrasound with Sonazoid for evaluating liver abscess in comparison with conventional B-mode ultrasound. Hepatol Res 45(3):337–342. https://doi.org/10.1111/hepr.12347 PubMedCrossRef

28.

Sainani NI, Arellano RS, Shyn PB, et al. (2013) The challenging image-guided abdominal mass biopsy: established and emerging techniques ‘if you can see it, you can biopsy it’. Abdom Imaging 38(4):672–696. https://doi.org/10.1007/s00261-013-9980-0 PubMedCrossRef

29.

Sparchez Z, Radu P, Zaharia T, et al. (2010) Contrast enhanced ultrasound guidance: a new tool to improve accuracy in percutaneous biopsies. Med Ultrasonogr 12(2):133–138

30.

Yoon SH, Lee KH, Kim SY, et al. (2010) Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound. Eur Radiol 20:2047–2056. https://doi.org/10.1007/s00330-010-1757-z PubMedCrossRef

31.

Mao F, Dong Y, Ji Z, Cao J, Wang WP (2017) Contrast-enhanced ultrasound guided biopsy of undetermined abdominal lesions: a multidisciplinary decision-making approach. Biomed Res Int 2017:8791259. https://doi.org/10.1155/2017/8791259 PubMedPubMedCentral

32.

Spârchez Z, Radu P, Kacsó G, et al. (2012) Contrast-enhanced ultrasound guided biopsy of super cial toraco-abdominal and neck lesions. Initial experience in 20 patients. Med Ultrasonogr 14(4):288–293

33.

Huang DY, Yusuf GT, Daneshi M, et al. (2017) Contrast-enhanced US-guided interventions: improving success rate and avoiding complications using US contrast agents. RadioGraphics 37(2):652–664. https://doi.org/10.1148/rg.2017160123 PubMedCrossRef

34.

Wang J, Zhou D, Xie X, Shen P, Zeng Y (2015) Utility of contrast-enhanced ultrasound with SonoVue in biopsy of small subpleural nodules. Int J Clin Exp Med 8(9):15991–15998PubMedPubMedCentral

35.

Ori Y, Neuman H, Chagnac A, et al. (2002) Using the automated biopsy gun with real-time ultrasound for native renal biopsy. Isr Med Assoc J 4(9):698–701PubMed

36.

Montvilas P, Solvig J, Johansen TE (2011) Single-centre review of radiologically guided percutaneous nephrostomy using “mixed” technique: success and complication rates. Eur J Radiol 80(2):553–558. https://doi.org/10.1016/j.ejrad.2011.01.109 PubMedCrossRef

37.

Liu BX, Huang GL, Xie XH, et al. (2017) Contrast-enhanced US-assisted percutaneous nephrostomy: a technique to increase success rate for patients with nondilated renal collecting system. Radiology 285(1):293–301PubMedCrossRef

38.

Chi T, Usawachintachit M, Weinstein S, et al. (2017) Contrast enhanced ultrasound as a radiation-free alternative to fluoroscopic nephrostogram for evaluating ureteral patency. J Urol . https://doi.org/10.1016/j.juro.2017.07.074

39.

Cui XW, Ignee A, Maros T, et al. (2016) Feasibility and usefulness of intra-cavitary contrast-enhanced ultrasound in percutaneous nephrostomy. Ultrasound Med Biol 42(9):2180–2188. https://doi.org/10.1016/j.ultrasmedbio.2016.04.015 PubMedCrossRef

40.

Ignee A, Baum U, Schuessler G, Dietrich CF (2009) Contrast-enhanced ultrasound-guided percutaneous cholangiography and cholangiodrainage (CEUS-PTCD). Endoscopy 41(8):725–726. https://doi.org/10.1055/s-0029-1214956 PubMedCrossRef

41.

Mao R, Xu EJ, Li K, Zheng RQ (2010) Usefulness of contrast-enhanced ultrasound in the diagnosis of biliary leakage following T-tube removal. J Clin Ultrasound JCU 38(1):38–40. https://doi.org/10.1002/jcu.20622 PubMed

42.

Xu EJ, Zheng RQ, Su ZZ, et al. (2012) Intra-biliary contrast-enhanced ultrasound for evaluating biliary obstruction during percutaneous transhepatic biliary drainage: a preliminary study. Eur J Radiol 81(12):3846–3850. https://doi.org/10.1016/j.ejrad.2012.06.025 PubMedCrossRef

43.

Meacock LM, Sellars ME, Sidhu PS (2010) Evaluation of gallbladder and biliary duct disease using microbubble contrast-enhanced ultrasound. Br J Radiol 83(991):615–627. https://doi.org/10.1259/bjr/60619911 PubMedPubMedCentralCrossRef

44.

Chen LD, Xu HX, Xie XY, et al. (2010) Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 20(3):743–753. https://doi.org/10.1007/s00330-009-1599-8 PubMedCrossRef

45.

Daneshi M, Rajayogeswaran B, Peddu P, Sidhu PS (2014) Demonstration of an occult biliary-arterial fistula using percutaneous contrast-enhanced ultrasound cholangiography in a transplanted liver. J Clin Ultrasound 42(2):108–111. https://doi.org/10.1002/jcu.22048 PubMedCrossRef

46.

Bruix J, Hessheimer AJ, Forner A, et al. (2006) New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 25(27):3848–3856. https://doi.org/10.1038/sj.onc.1209548 PubMedCrossRef

47.

Livraghi T, Goldberg SN, Lazzaroni S, et al. (2000) Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 214(3):761–768PubMedCrossRef

48.

Gillams AR, Lees WR (2009) Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19(5):1206–1213. https://doi.org/10.1007/s00330-008-1258-5 PubMedCrossRef

49.

Dominguez-Escrig JL, Sahadevan K, Johnson P (2008) Cryoablation for small renal masses. Adv Urol, Article ID 479495. https://doi.org/10.1155/2008/479495

50.

Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39(2):187–210. https://doi.org/10.1016/j.ultrasmedbio.2012.09.002 PubMedCrossRef

51.

Chen C, Liang P, Yu J, et al. (2016) Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound. Int J Hyperth 32(6):607–613. https://doi.org/10.3109/02656736.2016.1172118 CrossRef

52.

Nishigaki Y, Hayashi H, Tomita E, et al. (2015) Usefulness of contrast-enhanced ultrasonography using Sonazoid for the assessment of therapeutic response to percutaneous radiofrequency ablation for hepatocellular carcinoma. Hepatol Res 45(4):432–440. https://doi.org/10.1111/hepr.12370 PubMedCrossRef

53.

Minami Y, Kudo M, Kawasaki T, et al. (2004) Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 183(1):153–156PubMedCrossRef

54.

Dohmen T, Kataoka E, Yamada I, et al. (2012) Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma. Intern Med 51(1):1–7. https://doi.org/10.2169/internalmedicine.51.6042 PubMedCrossRef

55.

Lekht I, Gulati M, Nayyar M, et al. (2016) Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone. Abdom Radiol (NY) . https://doi.org/10.1007/s00261-016-0700-4

56.

Rhim H, Lee MH, Kim Y, et al. (2008) Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR Am J Roentgenol 190(5):1324–1330. https://doi.org/10.2214/AJR.07.2970 PubMedCrossRef

57.

Liu F, Yu X, Liang P, et al. (2011) Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound. Int J Hyperth 27(6):555–562. https://doi.org/10.3109/02656736.2011.564262 CrossRef

58.

Minami Y, Kudo M, Chung H, et al. (2007) Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. Am J Roentgenol 188(2):489–494. https://doi.org/10.2214/ajr.05.1286 CrossRef

59.

Numata K, Morimoto M, Ogura T, et al. (2008) Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med 27(3):395–406PubMedCrossRef

60.

Kim TK, Khalili K, Jang HJ (2015) Local ablation therapy with contrast-enhanced ultrasonography for hepatocellular carcinoma: a practical review. Ultrasonography 34(4):235–245. https://doi.org/10.14366/usg.15018 PubMedPubMedCentralCrossRef

61.

Wehle MJ, Thiel DD, Petrou SP, et al. (2004) Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 64(1):49–52. https://doi.org/10.1016/j.urology.2004.02.026 PubMedCrossRef

62.

Park BK, Kim CK, Choi HY, et al. (2010) Limitation for performing ultrasound-guided radiofrequency ablation of small renal masses. Eur J Radiol 75(2):248–252. https://doi.org/10.1016/j.ejrad.2009.03.050 PubMedCrossRef

63.

Veltri A, Garetto I, Pagano E, et al. (2009) Percutaneous RF thermal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques? Cardiovasc Intervent Radiol 32(1):76–85. https://doi.org/10.1007/s00270-008-9414-5 PubMedCrossRef

64.

Forman HP, Middleton WD, Melson GL, McClennan BL (1993) Hyperechoic renal cell carcinomas: increase in detection at US. Radiology 188(2):431–434PubMedCrossRef

65.

Tamai H, Takiguchi Y, Oka M, et al. (2005) Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 24:1635–1640PubMedCrossRef

66.

Carrafiello G, Mangini M, Fontana F, et al. (2010) Single-antenna microwave ablation under contrast-enhanced ultrasound guidance for treatment of small renal cell carcinoma: preliminary experience. Cardiovasc Intervent Radiol 33(2):367–374. https://doi.org/10.1007/s00270-009-9745-x PubMedCrossRef

67.

Zhao X, Wang W, Zhang S, et al. (2012) Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Imaging 37(5):885–891PubMedCrossRef

68.

Lackey L, Peterson C, Barr RG (2012) Contrast-enhanced ultrasound-guided radiofrequency ablation of renal tumors. Ultrasound Q 28(4):269–274. https://doi.org/10.1097/RUQ.0b013e318274de66 PubMedCrossRef

69.

Meloni MF, Andreano A, Franza E, Passamonti M, Lazzaroni S (2012) Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation? Eur J Radiol 81(8):e897–902. https://doi.org/10.1016/j.ejrad.2012.05.002 PubMedCrossRef

70.

Lu MD, Yu XL, Li AH, et al. (2007) Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Ultrasound Med Biol 33(11):1736–1749. https://doi.org/10.1016/j.ultrasmedbio.2007.05.004 PubMedCrossRef

71.

Morimoto M, Nozawa A, Numata K, et al. (2005) Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation. J Ultrasound Med 24(3):273–283PubMedCrossRef

72.

Lewis D, Ampong MA, Rio A, et al. (2009) Mushroom-cage gastrostomy tube placement in patients with amyotrophic lateral sclerosis: a 5-year experience in 104 patients in a single institution. Eur Radiol 19(7):1763–1771. https://doi.org/10.1007/s00330-009-1307-8 PubMedCrossRef

73.

Liu JB, Merton DA, Goldberg BB, et al. (2002) Contrast-enhanced two- and three-dimensional sonography for evaluation of intra-abdominal hemorrhage. J Ultrasound Med 21(2):161–169PubMedCrossRef

74.

Catalano O, Lobianco R, Cusati B, Siani A (2005) Contrast-enhanced sonography for diagnosis of ruptured abdominal aortic aneurysm. AJR Am J Roentgenol 184(2):423–427PubMedCrossRef

75.

Durkin N, Deganello A, Sellars ME, et al. (2016) Post-traumatic liver and splenic pseudoaneurysms in children: diagnosis, management, and follow-up screening using contrast enhanced ultrasound (CEUS). J Pediatr Surg 51(2):289–292. https://doi.org/10.1016/j.jpedsurg.2015.10.074 PubMedCrossRef

76.

Yusuf GT, Sellars ME, Deganello A, Cosgrove DO, Sidhu PS (2017) Retrospective analysis of the safety and cost implications of pediatric contrast-enhanced ultrasound at a single center. AJR Am J Roentgenol 208(2):446–452. https://doi.org/10.2214/AJR.16.16700 PubMedCrossRef

77.

Anupindi SA, Biko DM, Ntoulia A, et al. (2017) Contrast-enhanced US assessment of focal liver lesions in children. Radiographics 37(6):1632–1647. https://doi.org/10.1148/rg.2017170073 PubMedCrossRef

78.

Sidhu PS, Cantisani V, Deganello A, et al. (2017) Role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med 38(1):33–43. https://doi.org/10.1055/s-0042-110394 PubMed

79.

Rafailidis V, Deganello A, Watson T, Sidhu PS, Sellars ME (2017) Enhancing the role of paediatric ultrasound with microbubbles: a review of intravenous applications. Br J Radiol 90(1069):20160556. https://doi.org/10.1259/bjr.20160556 PubMedCrossRef

80.

Deganello A, Rafailidis V, Sellars ME, et al. (2017) Intravenous and intracavitary use of contrast-enhanced ultrasound in the evaluation and management of complicated pediatric pneumonia. J Ultrasound Med . https://doi.org/10.1002/jum.14269

Title: Contrast-enhanced ultrasound (CEUS) in abdominal intervention
Authors: Dean Y. Huang
Gibran T. Yusuf
Mohammad Daneshi
Raymond Ramnarine
Annamaria Deganello
Maria E. Sellars
Paul S. Sidhu
Publication date: 01-04-2018
Publisher: Springer US
Published in: Abdominal Radiology / Issue 4/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-018-1473-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Machine learning for medical ultrasound: status, methods, and future opportunities

Artifacts in contrast-enhanced ultrasound: a pictorial essay

Practical advantages of contrast-enhanced ultrasound in abdominopelvic radiology

Contrast-enhanced ultrasound of benign liver lesions

Role of contrast-enhanced ultrasound in evaluation of the bowel

Applications of contrast-enhanced ultrasound in the pediatric abdomen

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage